June 15, 2021


After Devastating New Study, Is There A Future For Workplace Wellness – And Has Peloton Figured It Out?

This is a story about the tension between what we desperately want to believe and what the data suggest we should believe, and — surprise! — this isn’t about the contentious recent approval of the Biogen drug aducanumab for Alzheimer’s Disease. Rather, it’s about a powerful and important study just published in Health Affairs, examining the outcomes of a workplace wellness program in a...
Read More